Akin Gump Advises Baker Bros. Advisors LP in Exact Sciences Acquisition of Genomic Health
July 30, 2019
July 30, 2019
NEW YORK, July 30 -- Akin Gump Strauss Hauer and Feld, a law firm, issued the following news release:
Akin Gump advised Baker Bros. Advisors LP, the largest shareholder in Genomic Health, Inc., in the planned $2.8 billion sale of Genomic Health to Exact Sciences Corp.
Under the terms of the deal, Genomic Health stockholders will receive $27.50 per share in cash and $44.50 in Exact Sciences stock. The transaction, which was unanimously approved by the boards of directors . . .
Akin Gump advised Baker Bros. Advisors LP, the largest shareholder in Genomic Health, Inc., in the planned $2.8 billion sale of Genomic Health to Exact Sciences Corp.
Under the terms of the deal, Genomic Health stockholders will receive $27.50 per share in cash and $44.50 in Exact Sciences stock. The transaction, which was unanimously approved by the boards of directors . . .